top of page

Thyroid Health: Why a Normal TSH Doesn't Always Mean Your Thyroid Is Working Well

  • 4 days ago
  • 11 min read

Thyroid Health: Why a Normal TSH Doesn't Always Mean Your Thyroid Is Working Well

Your TSH is normal. Your medication dose has been reviewed and confirmed. By every measure your doctor is using, your thyroid is being managed correctly. But you are still exhausted by mid-morning. Still cold when everyone around you is comfortable. Still losing more hair than you should be. Still not feeling great, in ways you struggle to explain to people who ask if you are feeling better now that your thyroid is being treated.


This is one of the most consistent and one of the most overlooked patterns in thyroid health. And it has a clear physiological explanation, that can make all the difference to how you feel.


TSH and medication dose tell us one part of the story. They do not tell us whether thyroid hormone is actually reaching your cells in a form they can use.


How Common Is This?

Far more common than the clinical literature suggests, and far more common than most women are told. An Australian population-based study found that of women already taking thyroxine replacement therapy, 25% still had an abnormal TSH level. This means that even among women who are diagnosed and medicated, a significant proportion are not reaching optimal hormonal range. And that figure does not account for the many women whose TSH sits within range but whose free T3 is at the low end, whose reverse T3 is elevated, or whose thyroid antibodies are driving ongoing immune activity that medication doesn't always adequately address (PubMed, Australian population study).


Hashimoto's thyroiditis, the autoimmune condition that is the most common cause of hypothyroidism, affects women at rates ranging from 4.8% to 25.8% depending on the population studied. A 2023 systematic review and meta-analysis published in Frontiers in Endocrinology, analysing data from studies across 19 countries involving over 22 million participants, found a global prevalence of 7.5%. Women aged 30 to 50 are disproportionately affected, with women almost four times more likely to develop the condition than men (Frontiers in Endocrinology, 2023).


Hashimoto's is particularly relevant to this conversation because it is the condition most likely to produce the pattern described above. A woman with Hashimoto's may have her TSH normalised on medication and her dose adjusted over time, while the autoimmune process that is attacking the thyroid continues unchecked. Medication manages the hormonal consequence. It doesn't always address what is driving it. And that is where symptoms can persist.

 

What TSH Actually Measures

TSH, or thyroid stimulating hormone, is produced by the pituitary gland. Its role is to signal the thyroid to produce more hormone when the pituitary detects that levels in the blood are falling. A normal TSH tells us the pituitary is not detecting a significant shortfall. It does not tell us what happens next in the chain.


It does not tell us how much free T4, the storage form of thyroid hormone, is circulating. It does not tell us whether that T4 is converting to free T3, the active form cells actually use. It does not tell us whether reverse T3, an inactive form of thyroid hormone, is accumulating and blocking T3 receptors at the cellular level. And it does not tell us whether thyroid antibodies are present and actively attacking thyroid tissue.


Each of those requires its own marker. And the difference between what TSH shows and what a full panel reveals is often precisely where a woman's ongoing symptoms are located.

 

The Conversion Problem: Why Medication Is Not Always Enough

Most thyroid medication, thyroxine or levothyroxine, provides T4. T4 is the storage form of thyroid hormone and is largely inactive. For it to have any effect at the cellular level, it must first be converted to T3, the active hormone that regulates energy, metabolism, temperature, mood, cognitive function, and hair growth.


This conversion happens primarily in the liver, with a meaningful contribution from the gastrointestinal tract. It depends on enzymes called deiodinases, and those enzymes are impaired by several factors that are extremely common in women presenting with persistent thyroid symptoms despite normal TSH and adequate medication.


A 2025 review published in Frontiers in Cell and Developmental Biology confirmed that gut dysbiosis compromises intestinal barrier integrity, increasing bacterial endotoxin exposure in the bloodstream, which activates inflammatory signalling pathways that directly impair deiodinase enzyme synthesis and disrupt thyroid hormone conversion from T4 to T3. The review also confirmed that the gut microbiome plays a direct role in iodine absorption and thyroid hormone metabolism through microbial enzymes and immune cell interactions (Cadena-Ullauri et al., Frontiers in Cell and Developmental Biology, 2025).


Chronic stress is equally significant. Cortisol directly inhibits the deiodinase enzymes responsible for converting T4 to active T3, while simultaneously promoting conversion toward the inactive reverse T3. A woman managing a demanding workload, significant life stress, or disrupted sleep is likely to have cortisol patterns that actively work against thyroid function, regardless of what her TSH shows or how well her medication is dosed.


Nutritional deficiencies add a further layer. Selenium is required for T4 to T3 conversion and protects the thyroid from oxidative damage. Zinc supports thyroid hormone production and receptor sensitivity. Iron is required for the thyroid peroxidase enzyme essential for hormone synthesis. These deficiencies are common and rarely assessed. The result is a woman whose TSH is normal, whose medication dose is appropriate by all standard measures, and whose cells are still not receiving adequate active thyroid hormone. The medication is doing what it was prescribed to do. The conversion and delivery system is not. That distinction is where the naturopathic contribution sits.


“The most consistent pattern I see in clinic with thyroid patients is normal TSH, normal T4, and free T3 at the low end of range or reverse T3 elevated. The medication is working in the sense that T4 is being provided. The conversion is not working because gut dysbiosis, chronic stress, or nutritional deficiencies are impairing the enzymes responsible for it. Add Hashimoto’s into this and you also have an active autoimmune process that medication often isn't touching. When we address those factors, the symptoms that have persisted despite optimal medication often start to resolve.”

- Gemma Knaap, Naturopath (BHSc Naturopathy, Certified Natural Fertility Educator, Gut Microbiome Analyst)

Southernwood Apothecary & Clinic

 

Hashimoto's: The Autoimmune Driver

Hashimoto's thyroiditis deserves specific attention in this context because it is both the most common cause of hypothyroidism and the condition most likely to produce ongoing symptoms despite apparently adequate medical management.


In Hashimoto's, the immune system produces antibodies that attack thyroid tissue. Over time, this progressive immune attack damages the thyroid gland and impairs its ability to produce hormone. Thyroxine medication replaces what the damaged thyroid can no longer produce. What it cannot do is stop the immune attack, protect remaining thyroid tissue, or address the factors that are driving the autoimmune activity in the first place.


Hashimoto's is not simply hypothyroidism with a different label. It is a systemic immune condition that expresses in the thyroid. Women with Hashimoto's often have fluctuating symptoms, periods of feeling worse followed by relative improvement, and ongoing fatigue and cognitive symptoms that do not map neatly to their TSH level. This is because the immune activity that characterises the condition is variable, and TSH is measuring hormone output, not immune activity.


The factors that drive autoimmune activity in Hashimoto's are increasingly well characterised. Intestinal permeability, where a compromised gut barrier allows inflammatory compounds into systemic circulation, is a significant driver of immune dysregulation. Nutritional deficiencies, particularly in selenium and vitamin D, impair the regulatory immune processes that should be moderating the antibody response. Chronic stress suppresses regulatory immune function and can worsen autoimmune activity. Addressing these factors does not replace thyroxine. It works alongside it, targeting the immune process that medication alone doesn't address.

 

What a Full Thyroid Panel Looks Like

A thorough thyroid assessment includes five markers. Together they provide a more complete picture of thyroid hormone production, conversion, delivery, and immune status.

TSH: useful as a starting point but insufficient alone.

Free T4: the circulating storage form of thyroid hormone. Tells us whether the thyroid, or the medication replacing its output, is providing adequate T4.

Free T3: the active form cells actually use. Can be low even when TSH and T4 are normal, particularly when conversion is impaired by gut dysbiosis, cortisol elevation, or nutritional deficiency.

Reverse T3: an inactive form that competes with T3 at receptor sites. Elevated reverse T3 can produce hypothyroid symptoms even when other markers appear within range. Chronic stress is one of its most common drivers.

Thyroid antibodies (TPO and TgAb): elevated antibodies confirm Hashimoto's and are essential for directing management toward the autoimmune component, not only the hormonal one.

 

The Gut-Thyroid Axis

The connection between gut health and thyroid function is now well established in the research literature, and it is particularly relevant for women with Hashimoto's or conversion problems.


The gut microbiome influences iodine absorption, which is required for thyroid hormone synthesis. It influences deiodinase enzyme activity, which governs T4 to T3 conversion. It plays a central role in regulating the immune responses that determine whether autoimmune thyroid conditions develop or progress. And it affects the absorption of nutritional cofactors, selenium, zinc, and iron, that thyroid function depends on at multiple points.


In women with Hashimoto's, gut health is not a peripheral consideration. It is mechanistically connected to the autoimmune activity driving the condition. Improving gut health consistently produces improvement in thyroid symptom burden, often before other markers change, and it is one of the most reliable clinical levers available in this area of practice.

 

What Naturopathic Thyroid Support Contributes

Naturopathic thyroid support works alongside medical management, not instead of it. Thyroxine is an appropriate and effective medication for hypothyroidism, and for the majority of women with that diagnosis it is an important part of the overall approach. What it does not address is conversion, nutritional cofactors, gut health, cortisol patterns, or the autoimmune component in Hashimoto's.


In clinical practice, the assessment begins with reviewing the full thyroid panel where available, identifying nutritional deficiencies through testing, assessing gut health and inflammatory load, and reviewing the stress and cortisol contribution. From there, treatment is directed at the specific factors present for that individual.


Selenium supplementation at clinically relevant doses has been shown in randomised controlled trials to reduce thyroid antibody levels in Hashimoto's and to support T4 to T3 conversion. Gut health interventions addressing dysbiosis and intestinal permeability can meaningfully improve both conversion and immune regulation. Reducing the cortisol burden is a direct intervention on the conversion enzymes. And dietary strategies that reduce inflammatory load address the immune driver of antibody production in Hashimoto's.

For women on thyroxine who remain symptomatic, addressing these factors often produces the shift that medication alone has not delivered. Not because the medication was wrong, but because it was only addressing one part of a more complex and layered process.

 

There Is More to Investigate

A normal TSH and a correctly dosed medication are not the end of the thyroid conversation. They are the beginning of it.


If you have ongoing thyroid symptoms despite normal results, or you have Hashimoto's and the autoimmune component has never been specifically addressed, there is more that can be done. The relevant investigations are available, the underlying mechanisms are well understood, and the interventions that address them are evidence-based and targeted.

In person consultations are available at my Albany clinic. Telehealth consultations are available from anywhere in Australia.

 

 

 

Frequently Asked Questions

Why do I still have thyroid symptoms if my TSH is normal and my medication dose is correct?

TSH reflects what the pituitary detects and medication dose is typically adjusted to normalise this marker. Neither tells us whether T4 is converting adequately to active T3, whether reverse T3 is accumulating and blocking T3 receptors, or whether thyroid antibodies from Hashimoto's are driving ongoing immune activity. Many women with persistent symptoms have one or more of these factors unaddressed. A full thyroid panel including free T3, free T4, reverse T3, and thyroid antibodies provides a more complete assessment and regularly identifies what standard monitoring has missed.

T4 is the storage form of thyroid hormone and is largely inactive. It must be converted to T3, the active form, for cells to use it. Most thyroid medication provides T4. The conversion happens primarily in the liver and gut, and can be impaired by chronic stress, gut dysbiosis, nutritional deficiencies in selenium and zinc, and inflammation. A woman can have normal TSH and adequate T4 while still being functionally hypothyroid at the cellular level if this conversion is impaired.

Hashimoto's is an autoimmune condition in which the immune system attacks the thyroid gland, progressively damaging tissue and impairing hormone production. It is the most common cause of hypothyroidism in developed countries and affects women at rates up to four times higher than men. The critical distinction is that medication replaces the hormone the damaged thyroid can no longer produce, but does not stop the immune attack or address the factors driving it. Women with Hashimoto's often experience fluctuating symptoms that do not map neatly to their TSH level, because the immune activity varies independently of hormone output. Managing Hashimoto's effectively requires addressing the autoimmune component alongside any hormonal replacement.

Through several mechanisms. The gut microbiome influences iodine absorption required for thyroid hormone synthesis. It governs the activity of deiodinase enzymes that convert T4 to T3. A 2025 review in Frontiers in Cell and Developmental Biology confirmed that gut dysbiosis impairs deiodinase enzyme synthesis through inflammatory signalling pathways, directly disrupting T4 to T3 conversion. The gut microbiome also plays a central role in immune regulation, which is particularly relevant in Hashimoto's where autoimmune activity is the primary driver of thyroid damage.

Yes, significantly. Cortisol, the primary stress hormone, directly inhibits the deiodinase enzymes responsible for converting T4 to active T3, and promotes conversion toward inactive reverse T3 instead. This means chronic stress can produce or worsen functional hypothyroid symptoms at the cellular level even when TSH is normal and medication dose is appropriate. Cortisol also suppresses the regulatory immune function relevant to Hashimoto's, potentially worsening autoimmune activity. Managing the stress and cortisol is a clinically meaningful part of thyroid management, not a soft lifestyle recommendation.

Iodine is required for thyroid hormone synthesis. Selenium supports T4 to T3 conversion and protects the thyroid from oxidative damage. Randomised controlled trials have shown selenium supplementation reduces thyroid antibody levels in Hashimoto's. Zinc supports thyroid hormone production and receptor sensitivity. Iron is required for thyroid peroxidase, the enzyme essential for hormone synthesis. These deficiencies are common and rarely assessed in standard thyroid follow-up.

Yes. Naturopathic thyroid support addresses the factors that medication doesn't: T4 to T3 conversion, nutritional status, gut health, cortisol patterns, and where Hashimoto's is present, the autoimmune drivers of ongoing thyroid damage. For women on thyroxine who remain symptomatic, identifying and addressing these factors often produces meaningful improvement. This work complements medical management and is most effective when the two approaches operate alongside each other. In person consultations are available in Albany WA and Telehealth consultations are available across Australia.

 

 

 

About the Author

Gemma Knaap is a naturopath specialising in women's hormonal health, gut health, fertility, and reproductive wellbeing. She holds a Bachelor of Health Science in Naturopathy and is a Certified Natural Fertility Educator and Gut Microbiome Analyst. In person consultations are available at her Albany, WA clinic. Telehealth consultations are available across Australia.

 

 

 

References

Australian Thyroid Foundation. Hypothyroidism and Hashimoto's Disease. https://thyroidfoundation.org.au/Hypothyroidism-&-Hashimotos-Disease

Hollowell, J.G. et al. Prevalence of thyroid disease in an older Australian population. PubMed. https://pubmed.ncbi.nlm.nih.gov/17547723/

Hu, X. et al. (2022). Global prevalence and epidemiological trends of Hashimoto's thyroiditis in adults: A systematic review and meta-analysis. Frontiers in Public Health, 10, 1020709. https://doi.org/10.3389/fpubh.2022.1020709

Casadio, M. et al. (2023). Mapping the path towards novel treatment strategies: a bibliometric analysis of Hashimoto's thyroiditis research from 1990 to 2023. Frontiers in Endocrinology. https://doi.org/10.3389/fendo.2023.1277739

Cadena-Ullauri, S. et al. (2025). Microbiota dysbiosis impact on the metabolism of T3 and T4 hormones and its association with thyroid cancer. Frontiers in Cell and Developmental Biology, 13, 1589726. https://doi.org/10.3389/fcell.2025.1589726

PMC. (2025). Gut microbiota in hypothyroidism: pathogenic mechanisms and opportunities for precision microbiome interventions. https://pmc.ncbi.nlm.nih.gov/articles/PMC12521424/

Institute for Functional Medicine. (2024). Restoring Thyroid Hormone Balance. https://www.ifm.org/articles/balancing-thyroid-hormones-naturally

Comments


unnamed_edited.jpg
bottom of page